MRP Capital Investments’s Pfizer PFE Stock Holding History

MRP Capital Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.34M	Buy	47,763 +7,338	+18%	+$195K	1.17%	32
2025 Q4	$1.01M	Buy	40,425 +21,925	+119%	+$553K	0.84%	37
2025 Q3	$448K	Sell	18,500 -1,900	-9%	-$46.9K	0.39%	68
2025 Q2	$494K	Buy	20,400 +19,900	+3,980%	+$464K	0.34%	57
2025 Q1	$12.7K	Buy	500 +250	+100%	+$6.54K	0.01%	166
2024 Q4	$6.63K	Buy	+250	New	+$6.78K	0.01%	181
2023 Q4	–	Sell	-30,500	Closed	-$502K	–	105
2023 Q3	$502K	Buy	30,500 +3,709	+14%	+$131K	0.55%	57
2023 Q2	$983K	Sell	26,791 -975	-4%	-$38K	0.96%	34
2023 Q1	$1.13M	Buy	27,766 +11,407	+70%	+$493K	1.24%	27
2022 Q4	$838K	Buy	+16,359	New	+$784K	0.93%	35

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

MRP Capital Investments's PFE Position: Q1 2026 in Review

MRP Capital Investments increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $195K and bringing the position to 47,763 shares worth $1.34M. The position accounts for 1.17% of the portfolio, ranked #32.

MRP Capital Investments first reported a position in PFE in Q4 2022 and has held it in 10 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

MRP Capital Investments held 47,763 shares of Pfizer worth $1.34M as of Q1 2026.
MRP Capital Investments bought 7,338 Pfizer shares in Q1 2026, an estimated $195K.
Pfizer made up 1.17% of MRP Capital Investments's portfolio in Q1 2026, its #32 holding.
MRP Capital Investments first reported a position in Pfizer in Q4 2022 and has held it in 10 quarters since.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MRP Capital Investments's 13F filing for Q1 2026, filed 14 May 2026.